Keloids Treatment Market Report 2025

This report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.

The keloids treatment market size has grown strongly in recent years. It will grow from $4.14 billion in 2024 to $4.37 billion in 2025 at a compound annual growth rate (CAGR) of 5.5%. The growth in the historic period can be attributed to high prevalence of keloids, growing awareness keloid treatments, increasing incidence of wound and injury-related cases, rise in aesthetic surgeries.

The keloids treatment market size is expected to see steady growth in the next few years. It will grow to $5.17 billion in 2029 at a compound annual growth rate (CAGR) of 4.3%. The growth in the forecast period can be attributed to increasing expenditure on personal care products, government initiatives, increasing emphasis on scar prevention strategies, investments on keloids treatments. Major trends in the forecast period include advancements in treatment modalities, innovation in medical technologies, adanced minimally invasive procedures on keloids treatment, combination therapies, laser technology, scar management products.

The increasing incidence of wounds and injuries is expected to drive the growth of the keloid treatment market. A wound is a physical injury or damage to the body’s tissues, typically involving a break in the skin, caused by various factors such as accidents, surgeries, burns, or other traumatic events. The rise in wound occurrences contributes to keloid formation, heightening the demand for effective treatment options, boosting awareness of keloid-related complications, encouraging research advancements, and fostering collaboration among medical professionals. For instance, in December 2023, data from the Bureau of Labor Statistics, a U.S. government agency, reported that fatal work injuries in the United States rose to 5,486 in 2022, representing a 5.7% increase from 5,190 in 2021. This upward trend highlights a substantial rise in industrial accidents. Consequently, the growing incidence of wounds and injuries will drive expansion in the keloid treatment market.

Growing interest in non-surgical aesthetic procedures is expected to drive the keloid treatment market. Non-surgical aesthetics are cosmetic treatments aimed at enhancing appearance without surgery, addressing specific concerns for a more youthful look. Healthcare providers utilize non-surgical procedures like laser therapy, cryotherapy, and dermal fillers to minimize the appearance and symptoms of keloid scars, reducing inflammation, redness, and vascularization. For example, in September 2023, the International Society of Aesthetic Plastic Surgery, a U.S.-based organization, reported that in 2022, plastic surgeons performed over 14.9 million surgical and 18.8 million non-surgical procedures globally, marking an 11.2% increase overall. Consequently, the rising demand for non-surgical aesthetic procedures will propel the keloid treatment market forward.

Prominent companies operating in the keloid treatment market are strategically focusing on the development of innovative scar management technologies, such as Scar Erase silicone strips, to attain a competitive edge. For instance, in April 2023, Scar Erase, a UK-based scar treatment company, introduced Scar Erase silicone strips as a solution for scar treatment. These strips, composed of 3 mm medical-grade silicone, have demonstrated clinical efficacy in enhancing scar appearance and facilitating healing. They are reusable, vegan, cruelty-free, and offer a convenient and cost-effective at-home scar treatment option suitable for various scar types, including hypertrophic, keloid, post-surgery, and stretch marks. The technology involves encapsulating the scar with silicone to maintain hydration and create an optimal healing environment. This approach reduces collagen formation, improves scar texture, color, and height, delivering both effectiveness and comfort.

In March 2022, Alliance Pharma PLC, a UK-based pharmaceutical company, completed the acquisition of ScarAway from Perrigo Co. PLC for $19.4 million. This acquisition empowered Alliance Pharma to strengthen its presence in the U.S. consumer healthcare market, diversify its product portfolio, establish a global brand, boost revenue, and solidify its position as a market leader in scar treatment. ScarAway, a U.S.-based scar treatment brand specializing in keloids, played a pivotal role in this strategic move.

Major companies operating in the keloids treatment market are Pfizer Inc., F. Hoffmann-La Roche Ltd., Merck & Co. Inc., Novartis AG, Bristol-Myers Squibb Company, AstraZeneca PLC, GlaxoSmithKline plc., Eli Lilly and Company, Mylan N.V., Galderma S.A., Sun Pharmaceutical Industries Ltd., Molnlycke Health Care AB, Cynosure Inc., Cutera Inc., Alliance Pharma PLC, Revance Therapeutics Inc., Sensus Healthcare, Strata Skin Sciences, Avita Medical Limited, Pacific World Corporation, Mederma, Stratpharma AG, Sonoma Pharmaceuticals Inc., RXi Pharmaceuticals Inc., Biodermis, Novoxel Ltd., Scar Heal Inc., Galena Biopharma Inc.

North America was the largest region in the keloids treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in keloids treatment report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the keloids treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, and Spain.

The keloids treatment market consists of revenues earned by entities by providing dermatology consultations, follow-up and monitoring and patient education and counseling. The market value includes the value of related goods sold by the service provider or included within the service offering. The keloids treatment market also includes sales of topical creams and gels, silicone sheets and patches and dermal fillers, which are used in keloids treatment. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

Keloids refer to raised, thickened scars that extend beyond the original boundaries of a wound or injury. These scars result from an overgrowth of collagen during the healing process, leading to a firm, often discolored and sometimes uncomfortable or itchy area on the skin. Keloids can be treated using various medical interventions and approaches tailored to the individual's condition and the severity of the keloid.

The main types of keloids treatment are radiation therapy, cryotherapy, surgical treatment, laser treatment, steroid injections, interferon and others. Radiation therapy is a medical treatment that uses high doses of targeted radiation to target and destroy abnormal cells, such as keloid cells, aiming to inhibit the overgrowth of cells and reduce the size of keloids, which helps prevent keloid recurrence by damaging the cells that contribute to their formation. Keloids treatment also includes products such as elastic wraps, sprays, ointments, creams, oils, topical gels and gel sheets and others administered orally and parenterally by end users such as hospitals, homecare, dermatology clinics and others.

The keloids treatment market research report is one of a series of new reports that provides keloids treatment market statistics, including keloids treatment industry global market size, regional shares, competitors with a keloids treatment market share, detailed keloids treatment market segments, market trends and opportunities and any further data you may need to thrive in the keloids treatment industry. This keloids treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.